Teleflex Incorporated (NYSE:TFX) Director George Babich, Jr. sold 2,500 shares of Teleflex stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $252.57, for a total value of $631,425.00. Following the transaction, the director now directly owns 10,259 shares in the company, valued at approximately $2,591,115.63. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of Teleflex Incorporated (NYSE:TFX) traded down $0.25 during trading on Tuesday, reaching $254.95. The company had a trading volume of 170,277 shares, compared to its average volume of 286,536. The company has a market capitalization of $11,386.20, a price-to-earnings ratio of 31.24, a P/E/G ratio of 1.86 and a beta of 1.15. Teleflex Incorporated has a 1-year low of $175.00 and a 1-year high of $288.78. The company has a quick ratio of 3.70, a current ratio of 4.72 and a debt-to-equity ratio of 0.88.
Several brokerages recently issued reports on TFX. Leerink Swann reaffirmed a “buy” rating and set a $321.00 target price (up previously from $307.00) on shares of Teleflex in a research report on Tuesday, January 30th. Stephens reaffirmed a “buy” rating and set a $300.00 target price on shares of Teleflex in a research report on Thursday, January 18th. ValuEngine cut Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Morgan Stanley lifted their target price on Teleflex from $274.00 to $290.00 and gave the company an “equal weight” rating in a research report on Friday, November 3rd. Finally, Jefferies Group lifted their price target on Teleflex from $270.00 to $295.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $283.89.
COPYRIGHT VIOLATION WARNING: “Teleflex Incorporated (TFX) Director Sells $631,425.00 in Stock” was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2018/02/13/teleflex-incorporated-tfx-director-sells-631425-00-in-stock.html.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.